SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-054879
Filing Date
2014-02-14
Accepted
2014-02-14 16:27:00
Documents
1
Group Members
ANDERS HOVEBRYAN ROBERTSVHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d676712dsc13g.htm SC 13G 138980
  Complete submission text file 0001193125-14-054879.txt   140681
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86177 | Film No.: 14617164
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94306
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94306 650-561-9580
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G